Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$11.23 - $19.59 $188,776 - $329,307
-16,810 Reduced 59.44%
11,469 $158,000
Q1 2022

Apr 27, 2022

SELL
$13.37 - $17.79 $33,438 - $44,492
-2,501 Reduced 8.13%
28,279 $460,000
Q4 2021

Jan 31, 2022

BUY
$14.28 - $19.53 $140,600 - $192,292
9,846 Added 47.03%
30,780 $501,000
Q3 2021

Nov 03, 2021

SELL
$12.99 - $20.47 $38,450 - $60,591
-2,960 Reduced 12.39%
20,934 $311,000
Q1 2021

Apr 29, 2021

BUY
$19.33 - $37.75 $313,358 - $611,965
16,211 Added 211.0%
23,894 $551,000
Q4 2020

Jan 28, 2021

SELL
$24.48 - $42.47 $14,051 - $24,377
-574 Reduced 6.95%
7,683 $190,000
Q3 2020

Oct 29, 2020

BUY
$39.09 - $53.44 $101,164 - $138,302
2,588 Added 45.65%
8,257 $342,000
Q2 2020

Jul 24, 2020

BUY
$46.7 - $92.04 $101,105 - $199,266
2,165 Added 61.79%
5,669 $272,000
Q1 2020

Apr 29, 2020

BUY
$48.35 - $118.68 $169,418 - $415,854
3,504 New
3,504 $221,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.